EPISODE · Nov 19, 2020 · 5 MIN
Pfizer vaccine: an immunologist explains
from Naked Scientists, In Short Special Editions Podcast · host The Naked Scientists
Pfizer and BioNTech have concluded the Phase 3 trial of their coronavirus vaccine. The results appear to show an efficacy rate of 95%, and the developers hope to win FDA approval as soon as possible. This vaccine - a promising hope for many - works via a new methiod that's never been tried before in humans. Chris Smith asked Cambridge University immunologist Clare Bryant for her reaction... Like this podcast? Please help us by supporting the Naked Scientists
What this episode covers
Pfizer and BioNTech have concluded the Phase 3 trial of their coronavirus vaccine. The results appear to show an efficacy rate of 95%, and the developers hope to win FDA approval as soon as possible. This vaccine - a promising hope for many - works via a new methiod that's never been tried before in humans. Chris Smith asked Cambridge University immunologist Clare Bryant for her reaction... Like this podcast? Please help us by supporting the Naked Scientists
NOW PLAYING
Pfizer vaccine: an immunologist explains
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m